Jun 5, 2023, 15:54 by

Notes to Editor: About Emmes Founded more than 45 years ago, Emmes is a global, full-service Clinical Research Organization dedicated to excellence in supporting the advancement of public health and biopharmaceutical innovation. The company’s clients include numerous agencies and institutes of the U.S. federal government and a wide range of biotechnology, pharmaceutical and medical device companies throughout the world. To learn more about how our research is making a positive impact on human health, go to the Emmes website at www.emmes.com. For media enquiries, please contact: Alex Heeley or Nidhi Narain De Facto Communications T: +44 (0) 203 735 8165 / +44 (0) 7769015043 E: n.narain@defacto.co.uk / a.heeley@defacto.co.uk

Jun 5, 2023, 15:54 by

Jun 5, 2023, 14:48 by

CTMC, a joint venture between MD Anderson Cancer Center and Resilience, celebrates one year since its founding to accelerate life-saving cell therapies reaching patients.

Jun 1, 2023, 01:00 by User Not Found

Clinical Research News | After embracing a research approach long used in the public health field, neuroscience investigators at the University of California, Riverside, (UCR) made some surprising discoveries about the Latino community—including the cultural realities driving conduct problems in preadolescent girls.

May 30, 2023, 10:40 by

May 30, 2023, 10:40 by

Hunan Huateng Pharmaceutical Co. Ltd. Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China Email: sales@huatengusa.com Website: https://us.huatengsci.com Zip code: 410205 Telephone: +86 731 89916275 Fax: +86 0731-82251112-818

May 30, 2023, 10:40 by

Biopharma PEG Scientific Inc. Address: 108 Water Street, Room 4D, Watertown, MA 02472, USA TEL: 1-857-366-6766 Fax: 617-206-9595 Email: sales@biochempeg.com Website:https://www.biochempeg.com/

May 30, 2023, 10:40 by

Synexa Life Sciences, a specialist biomarker and bioanalysis service provider, has announced its membership in the Coalition for Epidemic Preparedness Innovations (CEPI) esteemed Central Lab Network, to improve global epidemic preparedness. CEPI is an innovative partnership between public, private, philanthropic, and civil organizations to develop vaccines against future epidemics. This strategic partnership represents a significant milestone in Synexa's commitment to global health security and its dedication to fostering collaboration and innovation in epidemic preparedness and response.

May 30, 2023, 10:40 by

May 30, 2023, 10:31 by User Not Found

Clinical Research News | PCORI funding opportunities for comparative clinical effectiveness research; Carolina consortium gets NIH funding for health equity research, funding to grow Southeast Asia’s largest telehealth platform; more.

May 26, 2023, 01:00 by User Not Found

Clinical Research News | During the worst days of the COVID-19 pandemic, drug sponsors, clinical sites, and patients alike discovered the value of in-home services in allowing research studies to proceed while minimizing patients’ potential exposure to the virus from on-site visits. Such services were a lifeline to the research industry. Today, in-home services are being baked into trial protocols not out of dire necessity, but rather out of an appreciation for their value in supporting patient-centric trials with decentralised components.

May 25, 2023, 13:50 by

May 25, 2023, 13:50 by

May 25, 2023, 13:50 by

Oncodesign Services has announced it has entered into a Memorandum of Understanding with Veritas In Silico to respond to the needs of pharmaceutical companies seeking to develop innovative small molecule drugs targeting mRNA.

May 25, 2023, 13:50 by

May 24, 2023, 01:00 by User Not Found

Clinical Research News | Trialbee enhances recruitment strategy; Flatiron and Sanofi set out to redesign the clinical trial experience for sponsors, sites, and patients; and Phesi has published the first edition of its Digital Patient Profile (DPP) catalog. Plus: partnerships for Culmination Bio, Cofactor Genomics, Personalis, Ono Pharmaceuticals, National Cancer Center, and more.

May 23, 2023, 13:27 by User Not Found

Clinical Research News | Last week, CVS Health announced its intension to phase out of the clinical trial business with a full exit expected by the end of 2024. In a conversation with Clinical Research News, Walgreens Chief Clinical Trials Officer Ramita Tandon applauds her colleagues at CVS for being the first mover. She is also reassuring Walgreens stakeholders that “we are not going away.”

May 19, 2023, 14:04 by

Muehlhausen is a trusted name in independent, scientific evaluation of patient-facing technologies; also known for his ability to envision and develop groundbreaking solutions for eCOA/ePRO and wearables.

May 19, 2023, 14:04 by

May 19, 2023, 14:03 by

Lonza has launched the TheraPEAK® T-VIVO® Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamline CAR T-cell manufacturing.